Research Article
Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats
Table 5
Hematological values of female rats.
| Parameters | Single dose | Repeated dose | Vehicle control | 1.0 mg/kg | 10.0 mg/kg | 100.0 mg/kg | 10.0 mg/kg |
| RBC (1012/L) | 7.778 ± 0.219 | 7.584 ± 0.568 | 7.954 ± 0.424 | 8.042 ± 0.561 | 6.04 ± 0.37 | HCT (%) | 46.06 ± 0.6 | 45.34 ± 3.13 | 46.98 ± 1.22 | 47.16 ± 1.49 | 38.2 ± 1.34 | HGB (g/dL) | 14.92 ± 0.23 | 14.44 ± 1.06 | 14.9 ± 0.29 | 14.96 ± 0.47 | 11.62 ± 0.50 | MCV (fL) | 59.26 ± 1.3 | 59.86 ± 0.56 | 59.1 ± 1.71 | 58.8 ± 2.76 | 63.38 ± 2.38 | MCH (pg) | 19.2 ± 0.58 | 19.06 ± 0.27 | 18.78 ± 0.75 | 18.64 ± 1 | 19.25 ± 0.69 | MCHC (g/dL) | 32.38 ± 0.3 | 31.82 ± 0.47 | 31.76 ± 0.46 | 31.68 ± 0.33 | 30.4 ± 0.46 | ABRETIC (109/L) | 191.58 ± 55.04 | 226.5 ± 33.41 | 192.02 ± 21.07 | 215.84 ± 21.41 | 273.87 ± 31.75 | WBC (109/L) | 7.444 ± 1.547 | 8.022 ± 3.840 | 7.922 ± 1.865 | 7.28 ± 2.163 | 10.67 ± 1.900 | ABNEUT (109/L) | 1.146 ± 0.512 | 1.71 ± 1.516 | 1.128 ± 0.308 | 1.148 ± 0.434 | 2.53 ± 0.45 | ABLYMP (109/L) | 5.988 ± 1.053 | 5.956 ± 2.336 | 6.526 ± 1.92 | 5.886 ± 1.807 | 7.64 ± 1.61 | ABMONO (109/L) | 0.18 ± 0.08 | 0.228 ± 0.234 | 0.136 ± 0.034 | 0.142 ± 0.094 | 0.23 ± 0.08 | ABBASO (109/L) | 0.006 ± 0.005 | 0.006 ± 0.005 | 0.01 ± 0.007 | 0.008 ± 0.004 | 0.01 ± 0 | ABEOS (109/L) | 0.066 ± 0.011 | 0.072 ± 0.034 | 0.072 ± 0.032 | 0.06 ± 0.031 | 0.16 ± 0.07 | PLT (109/L) | 979.8 ± 82.6 | 1081.6 ± 83.2 | 1004.4 ± 93.7 | 987 ± 86.1 | 1357.67 ± 169.65 | MPV (fL) | 8.92 ± 0.25 | 9.02 ± 0.30 | 9.28 ± 0.20 | 9 ± 0.19 | 8.58 ± 0.42 | APTT (seconds) | 16.8 ± 0.65 | 16.94 ± 1.15 | 18.24 ± 1.36 | 17.02 ± 1.47 | 14.9 ± 0.28 | PT (seconds) | 20.04 ± 0.91 | 20.06 ± 0.75 | 19.44 ± 0.70 | 19.72 ± 0.50 | 20.45 ± 1.16 |
|
|
Values are expressed as mean ± SD.
|